Modulating insulin secretion and inflammation against sodium arsenite toxicity by levosimendan as a novel pancreatic islets’ protector

References

• Armandeh, M., et al., 2021. The role of levosimendan in phosphine-induced cardiotoxicity: evaluation of electrocardiographic, echocardiographic, and biochemical parameters. Toxicology mechanisms and methods, 31 (9), 631–643.
   PubMed Web of Science ®Google Scholar
• Armstrong, D., and Browne, R., 1994. the analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. In: D. Armstrong, ed., Free radicals in diagnostic medicine, advances in experimental medicine and biology. Boston, MA: Springer US, 43–58.
   Google Scholar
• Baeeri, M., et al., 2022. The effect of levosimendan on phosphine-induced nephrotoxicity: biochemical and histopathological assessment. Drug research, 72 (2), 109–118.
   Google Scholar
• Bahadar, H., et al., 2015. Assessment of benzene induced oxidative impairment in rat isolated pancreatic islets and effect on insulin secretion. Environmental toxicology and pharmacology, 39 (3), 1161–1169.
   PubMed Web of Science ®Google Scholar
• Barroso, I., et al., 1999. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature, 402 (6764), 880–883.
   PubMed Web of Science ®Google Scholar
• Benzie, I.F.F., and Strain, J.J., 1996. The Ferric Reducing Ability of Plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Analytical biochemistry, 239 (1), 70–76.
   PubMed Web of Science ®Google Scholar
• Bonaventura, M.M., et al., 2017. Arsenite in drinking water produces glucose intolerance in pregnant rats and their female offspring. Food and chemical toxicology, 100, 207–216.
   PubMed Web of Science ®Google Scholar
• Buege, J.A., and Aust, S.D., 1978. [30] Microsomal lipid peroxidation. In: Methods in enzymology. Amsterdam: Elsevier, 302–310.
   Google Scholar
• Burns, C.J., et al., 1999. The p38 mitogen-activated protein kinase cascade is not required for the stimulation of insulin secretion from rat islets of Langerhans. Molecular and cellular endocrinology, 148 (1–2), 29–35.
   PubMed Web of Science ®Google Scholar
• Carmean, C.M., and Seino, S., 2019. Braving the element: pancreatic β-cell dysfunction and adaptation in response to arsenic exposure. Frontiers in endocrinology, 10, 344.
   PubMed Web of Science ®Google Scholar
• Cholley, B., et al., 2019. Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper. Critical care, 23 (1), 385.
   PubMed Web of Science ®Google Scholar
• Cui, Q., et al., 2017. Deficiency of long isoforms of Nfe2l1 sensitizes MIN6 pancreatic β cells to arsenite-induced cytotoxicity. Toxicology and applied pharmacology, 329, 67–74.
   PubMed Web of Science ®Google Scholar
• Delgado-León, T.G., et al., 2018. Apoptosis in pancreatic β-cells is induced by arsenic and atorvastatin in Wistar rats with diabetes mellitus type 2. Journal of trace elements in medicine and biology, 46, 144–149.
   PubMed Web of Science ®Google Scholar
• DeMarsilis, A., et al., 2022. Pharmacotherapy of type 2 diabetes: an update and future directions. Metabolism, 137, 155332.
   PubMed Web of Science ®Google Scholar
• Díaz-Villaseñor, A., et al., 2008. Arsenite reduces insulin secretion in rat pancreatic β-cells by decreasing the calcium-dependent calpain-10 proteolysis of SNAP-25. Toxicology and applied pharmacology, 231 (3), 291–299.,
   PubMed Web of Science ®Google Scholar
• Díaz-Villaseñor, A., et al., 2006. Sodium arsenite impairs insulin secretion and transcription in pancreatic β-cells. Toxicology and applied pharmacology, 214 (1), 30–34.
   PubMed Web of Science ®Google Scholar
• Irvin-Barnwell, E.-A., et al., 2018. Environmental toxins found historically in the polycythemia vera cluster area and their potential for inducing DNA damage. Journal of environmental & analytical toxicology, 08 (01),
   Google Scholar
• Farmakis, D., et al., 2016. Levosimendan beyond inotropy and acute heart failure: evidence of pleiotropic effects on the heart and other organs: an expert panel position paper. International journal of cardiology, 222, 303–312.
   PubMed Web of Science ®Google Scholar
• Friberg, L., and Elinder, C.G., 1993. Biological monitoring of toxic metals. Scandinavian journal of work, environment & health., 19 (Suppl 1), 7–13.
   PubMedGoogle Scholar
• Fu, J., et al., 2010. Low-level arsenic impairs glucose-stimulated insulin secretion in pancreatic beta cells: involvement of cellular adaptive response to oxidative stress. Environmental health perspectives, 118 (6), 864–870.
   PubMed Web of Science ®Google Scholar
• Ghaemmaleki, F., et al., 2020. Estrogens counteract tributyltin-induced toxicity in the rat islets of Langerhans. Heliyon, 6 (3), e03562.
   PubMed Web of Science ®Google Scholar
• Griendling, K.K., et al., 2016. Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the american heart association. Circulation research, 119 (5), 110.
   Web of Science ®Google Scholar
• Grossini, E., et al., 2020. Levosimendan improves oxidative balance in cardiogenic shock/low cardiac output patients. Journal of clinical medicine, 9 (2), 373.
   PubMed Web of Science ®Google Scholar
• Hassan, F.I., et al., 2017. The relation between rice consumption, arsenic contamination, and prevalence of diabetes in South Asia. EXCLI journal, 16, 1132–1143.
   PubMed Web of Science ®Google Scholar
• Henquin, J.-C., 2004. Pathways in β-cell stimulus-secretion coupling as targets for therapeutic insulin secretagogues. Diabetes, 53 (suppl_3), S48–S58.
   PubMedGoogle Scholar
• Hu, M.L., and Dillard, C.J., 1994. Plasma SH and GSH measurement. Method enzymol, 233, 385–387.
   PubMed Web of Science ®Google Scholar
• Izquierdo-Vega, J.A., et al., 2006. Diabetogenic effects and pancreatic oxidative damage in rats subchronically exposed to arsenite. Toxicology letters, 160 (2), 135–142.
   PubMed Web of Science ®Google Scholar
• Jowzi, N., et al., 2016. Reduction of chlorpyrifos-induced toxicity in human lymphocytes by selected phosphodiesterase inhibitors. Pesticide biochemistry and physiology, 128 (2016), 57–62.
   PubMedGoogle Scholar
• Kaltreider, R.C., et al., 2001. Arsenic alters the function of the glucocorticoid receptor as a transcription factor. Environmental health perspectives, 109 (3), 245–251.
   PubMed Web of Science ®Google Scholar
• Khaksar, M.R., et al., 2017. Protective effects of cerium oxide and yttrium oxide nanoparticles on reduction of oxidative stress induced by sub-acute exposure to diazinon in the rat pancreas. Journal of trace elements in medicine and biology, 41, 79–90.
   PubMed Web of Science ®Google Scholar
• Khan, F., et al., 2020. Assessment of arsenic-induced modifications in the DNA methylation of insulin-related genes in rat pancreatic islets. Ecotoxicology and environmental safety, 201, 110802.
   PubMed Web of Science ®Google Scholar
• Kirkley, A.G., et al., 2018. Arsenic exposure induces glucose intolerance and alters global energy metabolism. American journal of physiology, 314 (2), R294–R303.
   Google Scholar
• Krychtiuk, K.A., et al., 2015. Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro. Thrombosis and haemostasis, 113 (2), 350–362.
   PubMed Web of Science ®Google Scholar
• Lin, A.W., et al., 1998. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes & development, 12 (19), 3008–3019.
   PubMed Web of Science ®Google Scholar
• Liu, S., et al., 2014. Arsenic induces diabetic effects through beta-cell dysfunction and increased gluconeogenesis in mice. Scientific reports, 4, 6894.
   PubMed Web of Science ®Google Scholar
• Martin, E.M., Stýblo, M., and Fry, R.C., 2017. Genetic and epigenetic mechanisms underlying arsenic-associated diabetes mellitus: a perspective of the current evidence. Epigenomics, 9 (5), 701–710.
   PubMed Web of Science ®Google Scholar
• Meloni, A.R., et al., 2013. GLP ‐1 receptor activated insulin secretion from pancreatic β‐cells: mechanism and glucose dependence. Diabetes, obesity & metabolism, 15 (1), 15–27.
   PubMed Web of Science ®Google Scholar
• Moncada, S., Palmer, R.M., and Higgs, E.A., 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological reviews, 43 (2), 109–142.
   PubMed Web of Science ®Google Scholar
• Navaei-Nigjeh, M., et al., 2018. Reduction of marginal mass required for successful islet transplantation in a diabetic rat model using adipose tissue–derived mesenchymal stromal cells. Cytotherapy, 20 (9), 1124–1142.
   PubMed Web of Science ®Google Scholar
• Niaz, K., et al., 2017. Effect of styrene exposure on plasma parameters, molecular mechanisms and gene expression in rat model islet cells. Environmental toxicology and pharmacology, 54, 62–73.
   PubMed Web of Science ®Google Scholar
• Parissis, J.T., et al., 2004. Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure. The American journal of cardiology, 93 (10), 1309–1312.
   PubMed Web of Science ®Google Scholar
• Rodríguez-González, R., et al., 2019. Effects of levosimendan on inflammation and oxidative stress pathways in a lipopolysaccharide-stimulated human endothelial cell model. Biological research for nursing, 21 (5), 466–472.
   PubMed Web of Science ®Google Scholar
• Sabir, S., et al., 2019. Role of cadmium and arsenic as endocrine disruptors in the metabolism of carbohydrates: inserting the association into perspectives. Biomedicine & pharmacotherapy, 114, 108802.
   PubMed Web of Science ®Google Scholar
• Santo-Domingo, J., et al., 2019. Glucose-dependent phosphorylation signaling pathways and crosstalk to mitochondrial respiration in insulin secreting cells. Cell communication and signaling, 17 (1), 14.
   PubMedGoogle Scholar
• Scheiermann, P., et al., 2009. Effects of intravenous and inhaled levosimendan in severe rodent sepsis. Intensive care medicine, 35 (8), 1412–1419.
   PubMed Web of Science ®Google Scholar
• Schwarte, L.A., et al., 2011. The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxia. Intensive care medicine, 37 (4), 701–710.
   PubMed Web of Science ®Google Scholar
• Shiri, M., et al., 2016. Blockage of both the extrinsic and intrinsic pathways of diazinon-induced apoptosis in PaTu cells by magnesium oxide and selenium nanoparticles. International journal of nanomedicine, 11, 6239–6250. Volume
   PubMed Web of Science ®Google Scholar
• Tsao, C.-M., et al., 2014. Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model. Critical care, 18 (6), 652.
   PubMed Web of Science ®Google Scholar
• Wauson, E.M., Langan, A.S., and Vorce, R.L., 2002. Sodium arsenite inhibits and reverses expression of adipogenic and fat cell-specific genes during in vitro adipogenesis. Toxicological sciences, 65 (2), 211–219.
   PubMed Web of Science ®Google Scholar
• Winther, J.R., and Thorpe, C., 2014. Quantification of thiols and disulfides. Biochimica et Biophysica Acta, 1840 (2), 838–846.
   PubMed Web of Science ®Google Scholar
• Wu, M.-M., et al., 2003. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environmental health perspectives, 111 (11), 1429–1438.
   PubMed Web of Science ®Google Scholar
• Zhu, X.-X., et al., 2014. Sodium arsenite induces ROS-dependent autophagic cell death in pancreatic β-cells. Food and chemical toxicology, 70, 144–150.
   PubMed Web of Science ®Google Scholar